Supported by grants from the Swedish Research Council (2010-4286; PAO), the Faculty of Medicine, Umeå University, a Young Researcher Award from Umeå University (PAO), the World Anti Doping Agency (08C06CM; CM), Vinnova (2009-00462; CM), and Innovationsbron Umeå (2008; CM).
Transfusion of cryopreserved human red blood cells into healthy humans is associated with rapid extravascular hemolysis without a proinflammatory cytokine response
Version of Record online: 21 MAY 2012
© 2012 American Association of Blood Banks
Volume 53, Issue 1, pages 28–33, January 2013
How to Cite
Hult, A., Malm, C. and Oldenborg, P.-A. (2013), Transfusion of cryopreserved human red blood cells into healthy humans is associated with rapid extravascular hemolysis without a proinflammatory cytokine response. Transfusion, 53: 28–33. doi: 10.1111/j.1537-2995.2012.03710.x
- Issue online: 8 JAN 2013
- Version of Record online: 21 MAY 2012
- Received for publication December 21, 2011; revision received March 30, 2012, and accepted April 4, 2012.
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.